Literature DB >> 31663858

Accuracy of a Chatbot (Ada) in the Diagnosis of Mental Disorders: Comparative Case Study With Lay and Expert Users.

Stefanie Maria Jungmann1, Timo Klan1, Sebastian Kuhn2, Florian Jungmann2.   

Abstract

BACKGROUND: Health apps for the screening and diagnosis of mental disorders have emerged in recent years on various levels (eg, patients, practitioners, and public health system). However, the diagnostic quality of these apps has not been (sufficiently) tested so far.
OBJECTIVE: The objective of this pilot study was to investigate the diagnostic quality of a health app for a broad spectrum of mental disorders and its dependency on expert knowledge.
METHODS: Two psychotherapists, two psychology students, and two laypersons each read 20 case vignettes with a broad spectrum of mental disorders. They used a health app (Ada-Your Health Guide) to get a diagnosis by entering the symptoms. Interrater reliabilities were computed between the diagnoses of the case vignettes and the results of the app for each user group.
RESULTS: Overall, there was a moderate diagnostic agreement (kappa=0.64) between the results of the app and the case vignettes for mental disorders in adulthood and a low diagnostic agreement (kappa=0.40) for mental disorders in childhood and adolescence. When psychotherapists applied the app, there was a good diagnostic agreement (kappa=0.78) regarding mental disorders in adulthood. The diagnostic agreement was moderate (kappa=0.55/0.60) for students and laypersons. For mental disorders in childhood and adolescence, a moderate diagnostic quality was found when psychotherapists (kappa=0.53) and students (kappa=0.41) used the app, whereas the quality was low for laypersons (kappa=0.29). On average, the app required 34 questions to be answered and 7 min to complete.
CONCLUSIONS: The health app investigated here can represent an efficient diagnostic screening or help function for mental disorders in adulthood and has the potential to support especially diagnosticians in their work in various ways. The results of this pilot study provide a first indication that the diagnostic accuracy is user dependent and improvements in the app are needed especially for mental disorders in childhood and adolescence. ©Stefanie Maria Jungmann, Timo Klan, Sebastian Kuhn, Florian Jungmann. Originally published in JMIR Formative Research (http://formative.jmir.org), 29.10.2019.

Entities:  

Keywords:  (mobile) app; artificial intelligence; diagnostic; eHealth; mHealth; mental disorders; screening

Year:  2019        PMID: 31663858     DOI: 10.2196/13863

Source DB:  PubMed          Journal:  JMIR Form Res        ISSN: 2561-326X


  15 in total

1.  Obtaining patients' medical history using a digital device prior to consultation in primary care: study protocol for a usability and validity study.

Authors:  Klara Albrink; Carla Joos; Dominik Schröder; Frank Müller; Eva Hummers; Eva Maria Noack
Journal:  BMC Med Inform Decis Mak       Date:  2022-07-19       Impact factor: 3.298

2.  Rheumatic?-A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A Multicenter Pilot Validation Study.

Authors:  Rachel Knevel; Johannes Knitza; Aase Hensvold; Alexandra Circiumaru; Tor Bruce; Sebastian Evans; Tjardo Maarseveen; Marc Maurits; Liesbeth Beaart-van de Voorde; David Simon; Arnd Kleyer; Martina Johannesson; Georg Schett; Tom Huizinga; Sofia Svanteson; Alexandra Lindfors; Lars Klareskog; Anca Catrina
Journal:  Front Med (Lausanne)       Date:  2022-04-25

3.  Analyzing the determinants to accept a virtual assistant and use cases among cancer patients: a mixed methods study.

Authors:  Martien J P van Bussel; Gaby J Odekerken-Schröder; Carol Ou; Rachelle R Swart; Maria J G Jacobs
Journal:  BMC Health Serv Res       Date:  2022-07-09       Impact factor: 2.908

4.  Study protocol for a prospective, double-blinded, observational study investigating the diagnostic accuracy of an app-based diagnostic health care application in an emergency room setting: the eRadaR trial.

Authors:  S Fatima Faqar-Uz-Zaman; Natalie Filmann; Dora Mahkovic; Michael von Wagner; Charlotte Detemble; Ulf Kippke; Ursula Marschall; Luxia Anantharajah; Philipp Baumartz; Paula Sobotta; Wolf O Bechstein; Andreas A Schnitzbauer
Journal:  BMJ Open       Date:  2021-01-08       Impact factor: 2.692

5.  Utilization of Self-Diagnosis Health Chatbots in Real-World Settings: Case Study.

Authors:  Xiangmin Fan; Daren Chao; Zhan Zhang; Dakuo Wang; Feng Tian; Xiaohua Li
Journal:  J Med Internet Res       Date:  2021-01-06       Impact factor: 5.428

6.  Examining the effect of explanation on satisfaction and trust in AI diagnostic systems.

Authors:  Lamia Alam; Shane Mueller
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-03       Impact factor: 2.796

7.  Accuracy and usability of a diagnostic decision support system in the diagnosis of three representative rheumatic diseases: a randomized controlled trial among medical students.

Authors:  Johannes Knitza; Koray Tascilar; Eva Gruber; Hannah Kaletta; Melanie Hagen; Anna-Maria Liphardt; Hannah Schenker; Martin Krusche; Jochen Wacker; Arnd Kleyer; David Simon; Nicolas Vuillerme; Georg Schett; Axel J Hueber
Journal:  Arthritis Res Ther       Date:  2021-09-06       Impact factor: 5.156

Review 8.  [Challenges of digitalization in trauma care].

Authors:  H Trentzsch; G Osterhoff; R Heller; U Nienaber; M Lazarovici
Journal:  Unfallchirurg       Date:  2020-11       Impact factor: 1.000

Review 9.  [Economic aspects of digitalization in orthopedics and trauma surgery].

Authors:  Dominik Pförringer; David Matusiewicz; Serafeim Tsitsilonis; Tobias Gehlen; David A Back
Journal:  Unfallchirurg       Date:  2020-11       Impact factor: 1.000

10.  Syndromic Surveillance Insights from a Symptom Assessment App Before and During COVID-19 Measures in Germany and the United Kingdom: Results From Repeated Cross-Sectional Analyses.

Authors:  Alicia Mehl; Francois Bergey; Caoimhe Cawley; Andreas Gilsdorf
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-09       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.